SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (1054)2/26/1998 6:54:00 AM
From: Zvi Yammer  Read Replies (1) of 2742
 
Rick.

The 26 million vs. 22 mil is simple.
22 mil. is actual as of the close of the Med-Tec buy back.
26 mil on 12/31 is "weighted" avg.

A WA eans you take the SUM of the NUmber of share soutstanding each Day and divide that by the number of days..

So for the 92 days (Oct 31,nov 30,dec 31) CIST
had 91 days with 26 mil and 1 day with 22 mil.
(26*91 + 22*1)/92 is much closer to 26 than 22. SO I do not think
that CIST is doing anything. However, I do agree that they failed to mention the 4mil buy back and as well while they mentioned the cancellation of the perio trial they also failed to provide any offsetting updates on the other trials underway. And what about the
possible extension of the BlueStone Contract??

They have 400,000 shares at a .25 so if they're out there's gonna be some overhang at that price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News